Ex parte PETTERSSON et al. - Page 2


              Appeal No.  2001-1412                                                        Paper No. 29                
              Application No.  08/629,177                                                  Page 2                      
                     Rutner et al.  (Rutner)                   4,256,725            Mar. 17, 1981                      
                     Freundlich et al.  (Freundlich)           4,857,454            Aug. 15, 1989                      
                     Diamandis et al.  (Diamandis)             5,089,423            Feb. 18, 1992                      
                     Deeg et al.  (Deeg)                       5,378,638            Jan.   3, 1995                     
                     Mair et al. (Mair), “Equivalent Early Sensitivities of Myoglobin, Creatine Kinase                 
                            MB Mass, Creatine Kinase Isoform Ratios, and Cardiac Troponins I and T                     
                            for Acute Myocardial Infarction,” Clinical Chemistry, Vol. 41, No. 9, pp. 1266-            
                            1272 (September 1995).                                                                     
                     Ohman et al. (Ohman), “Early detection of acute myocardial infarction: additional                 
                            diagnostic information from serum concentrations of myoglobin in patients                  
                            without ST elevation,” British Heart Journal, Vol. 63, pp. 335-338 (1990).                 
                     Rabitzsch et al. (Rabitzsch), “Immunoenzymometric Assay of Human Glycogen                         
                            Phosphorylase Isoenzyme BB in Diagnosis of Ischemic Myocardial Injury,”                    
                            Clinical Chemistry, Vol. 41, No. 7, pp. 966-978 (July 1995).                               
                     Xu et al. (Xu), “Simultaneous Quadruple-Label Fluorometric Immunoassay of                         
                            Thyroid-Stimulating Hormone, 17"-Hydroxyprogesterone, Immunoreactive                       
                            Trypsin, and Creatine Kinase MM Isoenzyme in Dried Blood Spots,” Clinical                  
                            Chemistry, Vol. 38, No. 10, pp. 2038-2043 (October 1992).                                  
                                                      ISSUES2                                                          

                     Claims 1-4, 7-9, 15-17, 20-22, 28-34, 40-45 and 51-54 stand rejected under                        
              35 U.S.C. § 103(a) as being unpatentable over Deeg in view of Rutner.  Claims 14, 27, 39                 
              and 50 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Deeg in view                   
              of Rutner as applied to claims 1-4, 7-9, 15-17, 20-22, 28-34, 40-45 and 51-54 above, and                 
              further in view of Freundlich taken with each of Ohman, Mair and Rabitzsch.  Claims 10-13,               
              23-26, 35-38 and 46-49 stand rejected under 35 U.S.C. § 103(a) as being unpatentable                     
              over Deeg in view of Rutner as applied to claims 1-4, 7-9, 15-17, 20-22, 28-34, 40-45 and                
              51-54 above, and further in view of Freundlich in view of Diamandis and Xu.  We reverse                  


                     According to the advisory action (Paper 22, mailed December 27, 1999), the examiner withdrew2                                                                                                
              the final rejection of claims 1-4, 7-17 and 20-54 under 35 U.S.C. § 112, first paragraph, in view of appellants’
              RESPONSE AFTER FINAL (Paper 21, filed November 30, 1999).                                                





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007